| Biomarker ID | 1866 |
| PMID | 30373654 |
| Year | 2018 |
| Biomarker | Methlyation Status of GSTP1 |
| Biomarker Basis | Methylation Based |
| Biomolecule | Methylation |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Methylated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: Biological oxidations, Metapathway biotransformation, Pathways in cancer, T cell receptor regulation of apoptosis, Metabolism |
| Experiment | Gleason Grade 1 Vs Gleason Grade 2-5 |
| Type of Biomarker | Prognostic |
| Cohort | 15 normal prostate tissues along with 74 Prostate cancer samples were selected for analysis. 30 patients had Gleason Grade 1 and 44 had Gleason Grade 2-5 |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.01 |
| Method Used | KAPA SYBR FAST qPCR Kit |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | NA |